COP:NYSEConocoPhillips Analysis
Data as of 2026-06-05 - not real-time
$117.78
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
ConocoPhillips is trading just below its short‑term moving average and above a well‑established support zone, while the 20‑day and 50‑day averages remain higher, indicating a modest short‑term downside bias. The RSI sits near the neutral midpoint and the MACD histogram has turned positive, suggesting emerging bullish momentum.
Fundamentally, the stock trades at a price‑to‑earnings multiple that is comfortably below the industry average and a forward PE that signals strong earnings growth ahead. The company delivered an earnings beat in Q1 despite a modest revenue decline, generated robust cash flow, and secured a long‑term LNG supply contract, all while maintaining a healthy dividend payout. Analyst consensus remains bullish with a target price offering roughly twenty percent upside.
Fundamentally, the stock trades at a price‑to‑earnings multiple that is comfortably below the industry average and a forward PE that signals strong earnings growth ahead. The company delivered an earnings beat in Q1 despite a modest revenue decline, generated robust cash flow, and secured a long‑term LNG supply contract, all while maintaining a healthy dividend payout. Analyst consensus remains bullish with a target price offering roughly twenty percent upside.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Quarterly earnings beat and strong cash generation
- Bullish MACD histogram signaling early upside
- Price positioned above a solid support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward earnings growth reflected in a low forward PE
- Analyst target price implying ~20% upside
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Exposure to energy‑transition and regulatory headwinds
- Elevated leverage relative to cash balances
- Steady dividend income and diversified global asset base
Key Metrics & Analysis
Financial Health
Revenue Growth-5.30%
Profit Margin12.33%
P/E Ratio20.0
ROE11.28%
ROA5.87%
Debt/Equity36.14
P/B Ratio2.2
Op. Cash Flow$18.0B
Free Cash Flow$5.3B
Industry P/E22.3
Technical Analysis
TrendNeutral
RSI47.0
Support$112.64
Resistance$126.00
MA 20$118.41
MA 50$122.07
MA 200$104.35
MACDBullish
VolumeStable
Fear & Greed Index88.77
Valuation
Fair Value$43.21
Target Price$142.77
Upside/Downside21.22%
GradeFair
TypeBlend
Dividend Yield2.82%
Risk Assessment
Beta-0.22
Volatility29.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.